Patients were surveyed about demographic
characteristics and coexisting conditions. Patients
were seen at the end of treatment (day 12), at the
test of cure (7 to 10 days after completion of the
prescribed 10-day course of therapy), and at the
1-month follow-up (day 40). Information about
clinical response and possible medication side effects
was obtained with the use of standardized
forms.